TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15672012

Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Mifepristone 100 mg
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Mifepristone 400 mg
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg
Number of subjects: 346

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study: 11982665

Group type: EXPERIMENTAL
Intervention: High-velocity resistance training (HI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-velocity resistance training (LO)
Number of subjects: 30
Study: 10326343

Group type: EXPERIMENTAL
Intervention: Acemannan hydrogel wound dressing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moist saline gauze dressing
Number of subjects: 30
Study: 7813413

Group type: EXPERIMENTAL
Intervention: 4,5,6,7‐tetrahydroisoxazolo[5,4‐c]pyridin‐3‐ol (THIP)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: THIP
Number of subjects: 9
Study: 2782650

Group type: EXPERIMENTAL
Intervention: Slow injection (250 sec) of 10 mg hypobaric tetracaine with epinephrine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fast injection (10 sec) of 10 mg hypobaric tetracaine with epinephrine
Number of subjects: 20
Study: 180195

Group type: EXPERIMENTAL
Intervention: Photodynamic inactivation with neutral red and light
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 6939841

Group type: EXPERIMENTAL
Intervention: Proximal brush
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Toothpicks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Toothbrush alone
Number of subjects: 19

Group type: COMPARATOR
Intervention: Toothbrush combined with toothpicks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Toothbrush combined with proximal brush
Number of subjects: 19
Study: 30982743

Group type: EXPERIMENTAL
Intervention: High-resistance starch, low-protein flour (50 g daily at lunch and dinner for 12 weeks)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: High-resistance starch, low-protein flour
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (protein-restriction diet with common staple)
Number of subjects: 75
Study: 28003374

Group type: EXPERIMENTAL
Intervention: Weight Loss
Number of subjects: 164

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Maintenance
Number of subjects: 164
Study: 25402418

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood SCT (APBSCT)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Autologous BMT (ABMT)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Higher numbers of mobilized CD34+ cells (both groups)
Number of subjects: 292
Study: 25029619

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 79
Study: 22703639

Group type: EXPERIMENTAL
Intervention: Communication skills training for physiotherapists (8 hours of training including handouts, workbooks, video examples, role-play, and discussion)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Waitlist control (physiotherapists did not receive communication skills training)
Number of subjects: 292
Study: 19478337

Group type: EXPERIMENTAL
Intervention: CHOPA (isocaloric beverage with added protein and vitamins)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CHO (isocaloric carbohydrate drink)
Number of subjects: 12
Study: 17225918

Group type: EXPERIMENTAL
Intervention: Low-fat milk products enriched with plant stanol esters (2 g of stanols per day for 5 weeks)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 199
Study: 15051639

Group type: EXPERIMENTAL
Intervention: Rhythm-control strategy
Number of subjects: 4059

Group type: COMPARATOR
Intervention: Rate-control strategy
Number of subjects: 4059
Study: 12549790

Group type: EXPERIMENTAL
Intervention: Adapted-double phototherapy (DP) using daylight fluorescent lamps
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional phototherapy (CP)
Number of subjects: 51
Study: 9715861

Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg PO BID for 12 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 7847212

Group type: EXPERIMENTAL
Intervention: Embolized group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonembolized group
Number of subjects: 0
Study: 2569394

Group type: EXPERIMENTAL
Intervention: 1 mg of somatostatin in 2 ml saline (Group I)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 1 mg of somatostatin in 10 ml saline (Group II)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Somatostatin in a loading dose of 250 micrograms followed by an infusion of 125 micrograms h-1 (Group III)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control of ventilation studies in Group I
Number of subjects: 25
Study: 776314

Group type: EXPERIMENTAL
Intervention: Nitrazepam (10 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thioridazine (25 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30694977

Group type: EXPERIMENTAL
Intervention: Higher-protein diet (50% carbohydrate, 20% fat, 30% protein)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Control diet (64% carbohydrate, 20% fat, 16% protein)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Overfeeding+inactivity (35% excess of basal energy requirements)
Number of subjects: 10
Study: 28154006

Group type: EXPERIMENTAL
Intervention: CABG without surgical ventricular reconstruction (n=934)
Number of subjects: 1411

Group type: EXPERIMENTAL
Intervention: CABG with surgical ventricular reconstruction (n=477)
Number of subjects: 1411

Group type: EXPERIMENTAL
Intervention: Overall CABG group (n=1411)
Number of subjects: 1411

Group type: EXPERIMENTAL
Intervention: Multivariable analysis
Number of subjects: 1411
Study: 26426861

Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg IV THC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23784379

Group type: EXPERIMENTAL
Intervention: Contralateral risk‐reducing mastectomy (CRRM)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-CRRM (control group)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: CRRM (after matching for oophorectomy, gene, grade and stage)
Number of subjects: 105
Study: 19997859

Group type: EXPERIMENTAL
Intervention: KetacFil (KF)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: PhotacFil (PF)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Herculite XRV (HX)
Number of subjects: 35
Study: 20017916

Group type: EXPERIMENTAL
Intervention: High-energy drink (Meltdown RTD); 140 ml administered in two 70 ml doses, separated by 30 min.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo; 140 ml administered in two 70 ml doses, separated by 30 min.
Number of subjects: 10
Study: 17550598

Group type: EXPERIMENTAL
Intervention: Azithromycin 10 mg/kg/day for 7 days followed by 5 mg/kg/day for the duration of the study (up to 6 weeks)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15581126

Group type: EXPERIMENTAL
Intervention: Own-race (Caucasian) faces
Number of subjects: 52

Group type: COMPARATOR
Intervention: Other-race (Chinese) faces
Number of subjects: 52
Study: 12488406

Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg every 28 days for 2 years)
Number of subjects: 1640

Group type: COMPARATOR
Intervention: CMF chemotherapy (six 28-day cycles)
Number of subjects: 1640
Study: 9797818

Group type: EXPERIMENTAL
Intervention: Granisetron via drip infusion with 100 ml of normal saline 30 minutes prior to CDDP administration (Group A)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Direct injection of granisetron into the CDDP containing bottle (Group B)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Granisetron (both methods)
Number of subjects: 34
Study: 7661057

Group type: EXPERIMENTAL
Intervention: Multiple identical angiographic projections
Number of subjects: 348
Study: 2473539

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aspirin + Iloprost
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aspirin + Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 6
Study: 338009

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate inhalation (800 microgram daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31482848

Group type: EXPERIMENTAL
Intervention: Telelactation services (unlimited, on-demand video calls with lactation consultants through a mobile phone app)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Telelactation services
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Telelactation users
Number of subjects: 102
Study: 28249970

Group type: EXPERIMENTAL
Intervention: Ibandronate (local bisphosphonate treatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline treatment)
Number of subjects: 60
Study: 26188922

Group type: EXPERIMENTAL
Intervention: Warfarin pharmacogenetics algorithms (10 selected algorithms)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Wadelius et al. algorithm
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Gage et al. algorithm
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Algorithms in general
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Wadelius et al. and Miao et al. algorithms
Number of subjects: 193
Study: 23952889

Group type: EXPERIMENTAL
Intervention: 1,200 mg of NAC
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 2,400 mg of NAC
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 21412846

Group type: EXPERIMENTAL
Intervention: Clozapine (300 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Haloperidol (15 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Risperidone (6 mg/day)
Number of subjects: 51
Study: 19365587

Group type: EXPERIMENTAL
Intervention: Clopidogrel 450 mg loading and 75 mg/d thereafter added to standard reperfusion therapy (group 2, n: 85)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Standard pharmacological reperfusion therapy (group 1, n: 90)
Number of subjects: 175
Study: 17460488

Group type: EXPERIMENTAL
Intervention: Lactobacillus LB (Lacteol) plus oral rehydration salts (ORS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo plus oral rehydration salts (ORS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lactobacillus LB (Lacteol)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 15492476

Group type: EXPERIMENTAL
Intervention: Eccentric dosing of nitrates (n=153)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Continuous dosing of nitrates (n=86)
Number of subjects: 573

Group type: COMPARATOR
Intervention: Nontreatment (n=334)
Number of subjects: 573
Study: 12146181

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9133767

Group type: EXPERIMENTAL
Intervention: Venlafaxine and therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo and therapy
Number of subjects: 33
Study: 8432296

Group type: EXPERIMENTAL
Intervention: Alteplase (10 mg bolus injection + 5000 IU heparin bolus injection, followed by 90 mg alteplase over 3 h)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Anistreplase (30 mg iv over 5 min)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Streptokinase (1.5 million U over 1 h)
Number of subjects: 270
Study: 3123043

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 10
Study: 29524796

Group type: EXPERIMENTAL
Intervention: Robotic-assisted surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional manual surgery
Number of subjects: 70
Study: 26488178

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 2898

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2898
Study: 24956323

Group type: EXPERIMENTAL
Intervention: Educational intervention led by a community health worker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community health worker intervention plus patient and family communication activation intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community health worker intervention plus problem-solving intervention
Number of subjects: 0
Study: 21874575

Group type: COMPARATOR
Intervention: Chevron osteotomy (CO)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Chevron‐Akin double osteotomy (CAO)
Number of subjects: 72
Study: 20156955

Group type: EXPERIMENTAL
Intervention: Composite primary endpoint (TLOVR in 13 trials)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Virological efficacy endpoint
Number of subjects: 51
Study: 17868006

Group type: COMPARATOR
Intervention: Zonisamide (50-100 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16197773

Group type: EXPERIMENTAL
Intervention: Disinfectant wipe
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dry wipe (Control)
Number of subjects: 36
Study: 12135034

Group type: EXPERIMENTAL
Intervention: 68 g polyethylene glycol (PEG) laxative
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 51 g polyethylene glycol (PEG) laxative
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 85 g polyethylene glycol (PEG) laxative
Number of subjects: 24
Study: 10426889

Group type: EXPERIMENTAL
Intervention: Butenafine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proprietary base cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: No application (negative control)
Number of subjects: 0
Study: 7546114

Group type: EXPERIMENTAL
Intervention: Non-thermal pulsed high-frequency electromagnetic energy treatment for 30 minutes twice daily for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Non-thermal pulsed high-frequency electromagnetic energy treatment
Number of subjects: 30
Study: 1400055

Group type: EXPERIMENTAL
Intervention: Isometric resistance training (30 isometric extension maximal voluntary contractions per day, 3 times per week for 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 4042525

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg and 100 mg combined)
Number of subjects: 60
Study: 29275880

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (10 mg/d)
Number of subjects: 2153

Group type: COMPARATOR
Intervention: Placebo for Rosuvastatin
Number of subjects: 2153

Group type: EXPERIMENTAL
Intervention: Candesartan with hydrochlorothiazide (HCTZ; 16 mg/12.5 mg/d)
Number of subjects: 2153

Group type: COMPARATOR
Intervention: Placebo for Candesartan with HCTZ
Number of subjects: 2153

Group type: EXPERIMENTAL
Intervention: Combination therapy (Rosuvastatin + Cand+HCTZ)
Number of subjects: 2153

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 2153
Study: 27050628

Group type: EXPERIMENTAL
Intervention: Adaptive working memory training (Cogmed; n=13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Non-adaptive training (active placebo; n=14)
Number of subjects: 27
Study: 26683478

Group type: EXPERIMENTAL
Intervention: HAPIFED (Healthy APproach to weIght management and Food in Eating Disorders)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CBT-E (Cognitive Behavioural Therapy-Enhanced)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HAPIFED
Number of subjects: 100

Group type: COMPARATOR
Intervention: CBT-E
Number of subjects: 100
Study: 23742208

Group type: EXPERIMENTAL
Intervention: Web-based, computer-tailored self-management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 0
Study: 21392751

Group type: EXPERIMENTAL
Intervention: Pelvic anteroposterior x‐ray
Number of subjects: 45
Study: 19049375

Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study: 16990190

Group type: EXPERIMENTAL
Intervention: Hydroxocobalamin (2.5, 5, 7.5, or 10 g intravenous doses)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 12959627

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate
Number of subjects: 0
Study: 11020518

Group type: EXPERIMENTAL
Intervention: FSH alone
Number of subjects: 22

Group type: COMPARATOR
Intervention: GnRH agonist combined with FSH
Number of subjects: 22
Study: 2191020

Group type: EXPERIMENTAL
Intervention: Endoscopic alcoholization of lesions preceded by intragastric instillation of norepinephrine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Antacids
Number of subjects: 28
Study: 6985989

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tolbutamide treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 31564269

Group type: EXPERIMENTAL
Intervention: Deep breathing exercises (DBE) given twice daily with 5-10 repetitions for 15-30 minutes for 14 sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Incentive spirometry (ISM) with steam inhalation and nebulization with beta 2 agonist for 15-20 minutes for 35-45 minutes twice daily for 7 days
Number of subjects: 30
Study: 27862831

Group type: EXPERIMENTAL
Intervention: Prostatic urethral lift (PUL)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 80
Study: 26264751

Group type: EXPERIMENTAL
Intervention: Hamstring-eccentric (ECC) exercise protocol
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Unstable-squatting (UNS) exercise protocol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 24389433

Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m² and carboplatin (AUC 6 mg/min/ml) plus panitumumab (2.5 mg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Paclitaxel 200 mg/m² and carboplatin (AUC 6 mg/min/ml) without panitumumab
Number of subjects: 19
Study: 20579989

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone, 400 mg twice a day from the day of embryo transfer
Number of subjects: 435

Group type: COMPARATOR
Intervention: No progesterone support
Number of subjects: 435
Study: 19702079

Group type: EXPERIMENTAL
Intervention: SFI 1 mL/kg after intubation and before blocking the aorta (Group E1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SFI 1 mL/kg after opening the aorta (Group E2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SFI 0.5 mL/kg twice, before blocking and after opening the aorta (Group E3)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal saline 1 mL/kg after intubation (Group C)
Number of subjects: 32
Study: 16551919

Group type: EXPERIMENTAL
Intervention: Bilateral superficial cervical plexus block with 0.25% bupivacaine 15 mL on each side
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Local anesthetic wound infiltration with 0.25% bupivacaine 20 mL
Number of subjects: 45

Group type: COMPARATOR
Intervention: No regional block administered (Control)
Number of subjects: 45
Study: 12571670

Group type: EXPERIMENTAL
Intervention: Exposure-based intervention (tasting sweet red pepper for 8 daily sessions)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reward-based intervention (choosing a sticker after eating red pepper)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 49
Study: 10933099

Group type: EXPERIMENTAL
Intervention: Fibreoptic bronchoscopy
Number of subjects: 51
Study: 9331228

Group type: EXPERIMENTAL
Intervention: 0.75 mg oral alprazolam
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.50 mg oral alprazolam
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.25 mg oral alprazolam
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 8355426

Group type: EXPERIMENTAL
Intervention: Group size of 13 with undesirable members (11:2 proportion)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Group size of 52 with desirable members (2:11 proportion)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Group size of 39
Number of subjects: 145
Study: 2441631

Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural anesthesia with 12 ml of 2% lidocaine at T12 interspace
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single dose epidural anesthesia with 2% lidocaine-0.2% tetracaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single dose epidural anesthesia with 2% lidocaine-fentanyl 50 micrograms
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single dose epidural anesthesia with bupivacaine 0.5%
Number of subjects: 80
Study: 30135045

Group type: EXPERIMENTAL
Intervention: Internet-based intervention (Living positive with HIV)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Attention-only waiting-list control
Number of subjects: 188
Study: 26705672

Group type: EXPERIMENTAL
Intervention: Manual Pressure Release (MPR)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: MPR/MKT (Manual Pressure Release combined with Kinesio taping)
Number of subjects: 31
Study: 25637294

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP) in addition to optimal medical therapy (OMT)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 600
Study: 23076819

Group type: EXPERIMENTAL
Intervention: ivermectin 2.25 % + abamectin 1.25 %
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ivermectin 3.15 %
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: doramectin 3.15 %
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 100
Study: 19837485

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 12